Home
>
National Drug Code (NDC)
>
Xeomin
Xeomin - 0259-1605-01 - (incobotulinumtoxinA)
Drug Information of Xeomin
| Product NDC: | 0259-1605 |
| Proprietary Name: | Xeomin |
| Non Proprietary Name: | incobotulinumtoxinA |
| Active Ingredient(s): | 50 [USP'U]/1 & nbsp; incobotulinumtoxinA |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Xeomin
| Product NDC: | 0259-1605 |
| Labeler Name: | Merz Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125360 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100901 |
Package Information of Xeomin
| Package NDC: | 0259-1605-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0259-1605-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
NDC Information of Xeomin
| NDC Code | 0259-1605-01 |
| Proprietary Name | Xeomin |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0259-1605-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE |
| Product NDC | 0259-1605 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | incobotulinumtoxinA |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20100901 |
| Marketing Category Name | BLA |
| Labeler Name | Merz Pharmaceuticals, LLC |
| Substance Name | BOTULINUM TOXIN TYPE A |
| Strength Number | 50 |
| Strength Unit | [USP'U]/1 |
| Pharmaceutical Classes | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
